Breaking News
November 14, 2018 - The mystery viruses far worse than flu
November 14, 2018 - Research highlights physical changes in the brain of self-injuring teen girls
November 14, 2018 - Speed and error rate of DNA synthesis influenced by DNA structure
November 14, 2018 - Cranberry consumption modifies impact of animal-based diet on gut health
November 14, 2018 - £500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs
November 14, 2018 - Trump Administration Finalizes Birth Control Coverage Opt-Out
November 14, 2018 - Modern life offers children almost everything they need, except daylight
November 14, 2018 - Getting better: A patient is more than a collection of numbers
November 14, 2018 - 20 Americans Die Each Day Waiting For Organs
November 14, 2018 - First bifacial molecule can invade double-stranded DNA or RNA
November 14, 2018 - Study finds lack of safety data for using flowers in cooking
November 14, 2018 - Statistical methods play key role in predicting efficacy of new drugs
November 14, 2018 - Health Tip: Limit Fat, Sugar and Salt in Your Child’s Diet
November 14, 2018 - CA 19-9 Blood Test (Pancreatic Cancer): MedlinePlus Lab Test Information
November 14, 2018 - Old drug could have new use helping sick premature babies
November 14, 2018 - Surgery, not antibiotics, should remain first-line treatment for appendicitis | News Center
November 14, 2018 - Researchers to develop sports-specific classification system for blind football
November 14, 2018 - Preschool children show awake responses to naptime nonsense words
November 14, 2018 - Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women
November 14, 2018 - Study sheds light on mechanisms that prevent autoimmune attack
November 14, 2018 - Sleep quality found to be worse for women who undergo surgical menopause
November 14, 2018 - One-hour cognitive behavioral therapy session reduces insomnia symptoms in prisoners
November 14, 2018 - New study provides deeper insight into chromosome segregation during mitosis
November 14, 2018 - Surgical menopause leads to more disrupted sleep than natural menopause
November 14, 2018 - Inhibition of one protein clears toxic clumps seen in Parkinson’s disease, study finds
November 14, 2018 - Appendix removal is linked to lower risk of Parkinson’s
November 14, 2018 - Lifting weights for less than an hour a week may reduce cardiovascular disease risk
November 14, 2018 - Pulmonary rehabilitation rarely received by hospitalized COPD patients despite health benefits
November 14, 2018 - New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers
November 14, 2018 - Regular head circumference assessment of preterm babies can help identify long-term IQ problems
November 14, 2018 - Brigham investigators examine opioid use among Massachusetts adolescents, prescription trends
November 14, 2018 - Study defines biomarker in response to treatment of castration-resistant prostate cancer
November 14, 2018 - Study identifies potential therapeutic strategy for patients with clear cell renal cancer
November 14, 2018 - Bausch Health Announces U.S. Launch of Bryhali (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis In Adults
November 14, 2018 - Alpha Fetoprotein (AFP) Tumor Marker Test: MedlinePlus Lab Test Information
November 14, 2018 - Researchers evaluate controversial treatment for Parkinson’s disease psychosis
November 14, 2018 - AI could help veterinarians code their notes
November 14, 2018 - Pre-schoolers with autism thrive in mainstream classroom settings
November 14, 2018 - Individual and work-related factors may help promote hospital physician engagement, finds study
November 14, 2018 - Complementary and alternative medicine is widely used by general population in England
November 14, 2018 - Study reveals link between tobacco availability and smoking during pregnancy
November 14, 2018 - Purdue researchers develop translucent base for silicon patches to deliver exact doses of biomolecules
November 14, 2018 - New technology based on moths and magnets could help treat genetic diseases
November 14, 2018 - Concussion-Related Biomarkers Vary Based on Sex, Race
November 14, 2018 - One more year of high school may shape waistlines later in life
November 14, 2018 - Dissecting high drug costs – Scope
November 14, 2018 - Study shows novel strategy to reduce breast cancer bone metastasis
November 14, 2018 - Empowering the NHS through Industry Partnerships
November 14, 2018 - One size does not fit all in obesity treatment, study finds
November 14, 2018 - Seeking ways to prevent ‘secondary cataracts’
November 14, 2018 - Change Within the Eye May Be Early Warning for Macular Degeneration
November 14, 2018 - Study of 500,000 people clarifies the risks of obesity
November 14, 2018 - Ultrasound releases drug to alter activity in targeted brain areas in rats | News Center
November 14, 2018 - Umass Amherst researchers battle against youth suicide in rural Alaska Native communities
November 14, 2018 - Cancer stem cells depend on amino acid metabolism, and it’s proving to be their Achilles’ heel
November 14, 2018 - Epigenetic link found between prenatal exposure to maternal smoking and offspring’s cardio-metabolic health
November 14, 2018 - Meditation, music may change biomarkers of cellular aging and Alzheimer’s disease in older adults
November 14, 2018 - Multidisciplinaryresearch teams selected to study age-related brain disorders
November 14, 2018 - The Current issue of “The view from here” is concerned with Informatics
November 14, 2018 - Researchers identify tool to help transgender women have a more authentic voice
November 14, 2018 - Four faculty members appointed to endowed professorships | News Center
November 13, 2018 - Research finds strongest evidence yet that obesity causes depression
November 13, 2018 - Researchers compare stools of breastfed and formula-fed infants
November 13, 2018 - Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine
November 13, 2018 - Gene changes driving myopia reveal new focus for drug development
November 13, 2018 - $6 million grant to support study of preeclampsia, atherosclerosis links | News Center
November 13, 2018 - Beneficial gut microbes metabolize high-fiber diet to improve heart health in mouse model
November 13, 2018 - Excessive use of social media through visual postings linked to increase in narcissistic traits
November 13, 2018 - Study finds why obesity both fuels cancer growth and helps immunotherapy to kill tumors
November 13, 2018 - Women prefer and invest more in daughters, while men favor sons
November 13, 2018 - With hospitalization losing favor, judges order outpatient mental health treatment
November 13, 2018 - Transgenic rat model may provide new insights into cerebral amyloid angiopathy
November 13, 2018 - Study identifies factors tied to greater risk of advanced liver disease in cystic fibrosis patients
November 13, 2018 - Risk of blindness among premature babies with low levels of blood platelets
November 13, 2018 - A new strategy for combatting antibiotic-resistant infections
November 13, 2018 - Study aims to find which outreach method is more effective at improving cancer screening rates
November 13, 2018 - Insufficient sleep duration linked with unhealthy lifestyle profile among children
November 13, 2018 - IIASA researchers introduce new, simple measure for human wellbeing
November 13, 2018 - Magnetic nanosprings used as targeted drug delivery agents for anticancer therapy
November 13, 2018 - Scientists examine FCMs containing silver nanoparticles
Antioxidant treatment may decrease cardiovascular risk in women with type 1 diabetes

Antioxidant treatment may decrease cardiovascular risk in women with type 1 diabetes

image_pdfDownload PDFimage_print

The high estrogen levels that typically afford younger women protection from cardiovascular disease appear to instead multiply their risk if they have type 1 diabetes, researchers say.

A new study is examining the blood vessel health of these women during normal estrogen peaks and valleys and seeing whether treatment with over-the-counter supplements can help restore protection.

“Why does this disparity and risk exist?” says Dr. Ryan A. Harris, clinical exercise and vascular physiologist at the Georgia Prevention Institute and Department of Population Health Sciences at the Medical College of Georgia at Augusta University.

Epidemiological data indicates women with type 1 diabetes have 2-3 times greater risk of cardiovascular disease than men with type 1, Harris says.

Estrogen seems to be key in the early, rapid aging of their cardiovascular system. Harris’ team has early evidence that in diabetes the sex hormone estrogen produces a double whammy that increases levels of damaging oxidative stress while dramatically decreasing blood vessels’ ability to dilate. More typically estrogen does just the opposite.

“When you have diabetes, estrogen turns into a bad guy,” Harris says. “It actually causes blood vessel constriction when you have high levels of estrogen.”

Even isolated in a dish, when you put estrogen on a blood vessel, it dilates, and when you put it on a diabetic blood vessel, it contracts.

“The whole point of the grant is to determine why this happens and what we can do about it,” says Harris, principal investigator on a new $3.3 million grant from the National Institutes of Health.

“Once we can identify why estrogen acts like a bad guy, why estrogen causes vasoconstriction instead of vasodilation in these women, then we could introduce non-pharmacological treatments throughout the menstrual cycle that could ultimately reduce their cardiovascular disease risk,” Harris says.

They are recruiting 90 premenopausal women with type 1 diabetes, and for comparison sake, 30 healthy premenopausal women and 45 demographically matched men with type 1, all ages 18-40 and without diagnosed cardiovascular disease or other known complications of diabetes.

Rather than giving the women more estrogen, they are using the natural high and low points of the sex hormone over the course of their natural cycle. They will look at vascular health before and two hours following treatment or placebo.

Some women with type 1 will take a cocktail of antioxidant vitamins C and E along with alpha lipoic acid, an antioxidant made by cells to help them use glucose as energy and eliminate free radicals produced from that conversion. While antioxidant therapy for a wide range of ills has gotten mixed results, the Harris team has documented their cocktail’s impact in aging adults and COPD and they have early evidence it also works in these women. In fact, the MCG researchers are the first to study the impact of antioxidants in women with type 1 throughout their menstrual cycle, Harris says. Other women will take resveratrol, a compound found in the skin of red grapes – and red wine – as well as peanuts and berries, and also thought to work as an antioxidant that can directly activate the protein Sirt1. Sirt1 lowers the reactive oxygen species produced by the endothelial cells that line blood vessels and increases the availability of nitric oxide, a powerful natural dilator of blood vessels. Levels of Sirt1 naturally increase in the high-estrogen days of the cycle, but the Harris team has preliminary evidence that diabetes decreases that healthy increase. In fact, Sirt1 levels are generally lower in people with diabetes.

A final group of women with type 1 will take a placebo.

“We are targeting two different pathways that we think contribute to why estrogen is bad in the presence of diabetes,” Harris says.

He expects the response of those treated to normalize to that of healthy controls. His lab has already seen an increase in blood vessel health at peak estrogen periods even in women without type 1.

For this study, the healthy female controls will not be treated but, for comparison sake, men with type 1 diabetes will be studied at two similar points and undergo the same treatment strategies. Men with type 1 do have an increased cardiovascular risk over those without it, Harris notes.

To look at blood vessel health, they are using flow-mediated dilation, or FMD, of the brachial artery. The brachial artery is the major blood vessel of the upper arm, and FMD is a noninvasive standard measure of how the endothelial lining of blood vessels is functioning, and relates to blood vessel function in the heart and small blood vessels and of nitric oxide availability. The technique has been shown to accurately predict future cardiovascular disease and events. They also are looking directly at blood vessel health in the microcirculation – where oxygen exchange actually takes place – of the skin.

Harris’ team has additional evidence that during high estrogen periods, levels of superoxide dismutase, a natural enzyme that breaks down harmful oxygen molecules, is decreased while markers of oxidative stress are up. High glucose levels are believed to increase levels of oxidative stress, which also inactivates nitric oxide, he says. That means in the face of higher levels of oxidative stress, blood vessels tend to contract rather than relax and high estrogen seems to compound that.

The investigators suspect that the more rigid blood vessels they see in young women at peak estrogen levels become cumulative, contributing to their higher risk of cardiovascular disease.

The current study should provide more evidence and insight, but a larger study may be needed before making treatment recommendations to patients, Harris says.

Peak estrogen levels occur during ovulation, which enables an egg to be released and the uterus to prepare for a potential pregnancy. This occurs during about day 12-14 of the menstrual cycle. The first day of bleeding is considered day 1 and estrogen – and progesterone – levels are low. Women with type 1 typically cycle normally with these usual peaks and valleys, Harris notes.

Sirt1 has been implicated in both type 1 and 2 diabetes, including playing a role in increasing inflammation in type 1. Sirt1’s many cardioprotective benefits include improved endothelial function and glucose homeostasis, reduced inflammation and lipid metabolism, even lower blood pressure.

Cardiovascular disease accounts for 80 percent of the mortality and 75 percent of hospitalizations related to diabetes. Type 1 diabetes accounts for 5-10 percent of the nearly 30 million Americans with diabetes. Obesity, a known cardiovascular risk, is a major risk factor as well for type 2 diabetes. However, patients with type 1 diabetes, an autoimmune disease in which their immune system attacks their insulin-producing cells, tend to be lean.

Source:

http://www.augusta.edu/mcg/

About author

Related Articles